<DOC>
<DOCNO>
EP-0016460
</DOCNO>
<TEXT>
<DATE>
19801001
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/62 C07C-231/12 C07C-103/28 A61P-25/00 A61K-31/215 C07C-231/00 C07D-213/80 C07C-67/00 A61P-25/04 C07C-235/46 C07D-213/00 <main>C07C-103/26</main> A61K-31/615 A61K-31/21 A61P-29/00 A61K-31/60 C07C-235/00 
</IPC-CLASSIFICATIONS>
<TITLE>
salicylamide esters having therapeutical activity, process for their preparation and related pharmaceutical composition.
</TITLE>
<APPLICANT>
neopharmed spait<sep>neopharmed s.p.a.<sep>neopharmed s.p.a.via pordoi, 18i-20021 baranzate di bollate milanoit<sep>neopharmed s.p.a.<sep>
</APPLICANT>
<INVENTOR>
reiner alberto<sep>reiner, alberto<sep>reiner, albertovia mentana, 13comoit<sep>reiner, alberto<sep>reiner, albertovia mentana, 13comoit<sep>
</INVENTOR>
<ABSTRACT>
esters of salicylamide with anti-inflammatory and  analgesic action are disclosed.  these esters have the following general formula:    wherein r is a radical of an acid selected amongst d-2- (6′-­ methoxy-2′-naphthyl)-propionic acid, 2-{[3-­ (trifluoromethyl)-phenyl]-amino}  -3- pyridinecarboxylic  acid, 2-(4- isobutyl-phenyl)-propionic acid, 4-allyloxy-­ 3-chloro- phenyl-acetic acid, 2-(3- benzoylphenyl)-propionic  acid, mefenamic acid and flufenamic acid.  the process for  preparing the subject esters comprises reacting a halide, pre­ ferably a chloride of the desired acid, with a solution of  salicylamide.  
</ABSTRACT>
</TEXT>
</DOC>
